You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -80.5% | -33.1% |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -1.4 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 1.3 | 1.5 |
Price / Book value | 0.7 |
Latest | Forecast | |
---|---|---|
Revenue | 13.2% | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2020-12-31 | 9.43 | -23.46 | -12.54p | -14.9 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | 25.16 | -30.34 | -14.48p | -9.9 | 0.0 | n/a | n/a | 0.0% |
2022-12-31 | 27.20 | -30.90 | -14.48p | -1.7 | 0.0 | n/a | n/a | 0.0% |
2023-12-31 | 30.80 | -24.50 | -7.00p | -6.6 | 0.0 | n/a | n/a | 0.0% |
Creo Medical eyes transition to full commercialisation in FY25 Sharecast News | 17 Feb |
---|---|
ABUHB initiates six month pilot of Creo Medical's Speedboat technology Sharecast News | 06 Feb |
Director dealings: Creo Medical chairman raises stake Sharecast News | 16 Dec |
Notice of Results | 15-Apr-25 14:00 |
---|---|
Holding(s) in Company | 01-Apr-25 09:34 |
Holding(s) in Company | 31-Mar-25 22:52 |
Grant of Options | 26-Mar-25 23:01 |
Appointment of Nominated Adviser and sole Broker | 06-Mar-25 23:01 |